Medsafe approves RSV prevention medicine for babies
New Zealand has approved an RSV prevention medicine for babies, with health officials now calling on Pharmac to fund it.
Medsafe has approved a medicine to prevent respiratory syncytial virus in babies. Health sector leaders including a cardiac and respiratory foundation chief executive and a paediatrician are urging Pharmac to provide funding for the treatment.
Covered by1NewsNot covered byRNZStuffNZ HeraldNewstalk ZBOtago Daily TimesNewsroomThe SpinoffBusinessDeskinterest.co.nz
Coverage across the news outlets we track, as at publication.
What outlets are saying
1News
Medsafe approves RSV prevention medicine for babies, Pharmac urged to fund
Cardiac and Respiratory Foundation chief executive Letitia Harding and paediatrician Maneesh Deva both urged Pharmac to fund the medicine.